STOCK TITAN

Heska Corporation to Present at the Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Heska Corporation (NASDAQ: HSKA) announced that President & CEO Kevin Wilson will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 1, 2020. The presentation will be available for registered attendees from November 23 to December 3, with an archived replay on Heska's website for 90 days afterward. Alongside the presentation, Mr. Wilson will hold one-on-one meetings on the conference day, which can be arranged through Piper Sandler or Heska Investor Relations.

Positive
  • None.
Negative
  • None.

LOVELAND, Colo., Nov. 24, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President & Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on Tuesday, December 1, 2020.

Mr. Wilson's fireside presentation with Piper Sandler will be available for registered attendees on the Piper Sandler conference site from November 23 to December 3. The webcast will be archived and a replay will be available on the Company's website for 90 days following the conference. 

Mr. Wilson and members of Heska management will be participating in one-on-one meetings on December 1.  Meetings may be requested via Piper Sandler or Heska Investor Relations at investorrelations@heska.com.

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/heska-corporation-to-present-at-the-upcoming-piper-sandler-32nd-annual-virtual-healthcare-conference-301179500.html

SOURCE Heska Corporation

FAQ

When is Heska presenting at the Piper Sandler conference?

Heska will present at the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 1, 2020.

How can I access Heska's presentation after the conference?

The presentation will be available for registered attendees from November 23 to December 3, and an archived replay will be available on Heska's website for 90 days.

Who will represent Heska at the Piper Sandler conference?

Kevin Wilson, Heska's President & CEO, will represent the company at the conference.

How can I request a meeting with Heska during the conference?

Meetings can be requested through Piper Sandler or by contacting Heska Investor Relations via email at investorrelations@heska.com.

HSKA

NASDAQ:HSKA

HSKA Rankings

HSKA Latest News

HSKA Stock Data

1.31B
10.24M
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Loveland